Docoh
Loading...

ATNF
180 Life Sciences Corp
KBL Merger Corp.
California
NASDAQ
ETNB
89bio Inc
89bio, Inc.
California
NASDAQ
NMTR
9 Meters Biopharma Inc
9 Meters Biopharma, Inc.
North Carolina
NASDAQ
ACIU
AC Immune SA
AC Immune SA engages in the discovery and development of therapeutic and diagnostic products for neurodegenerative diseases.
Switzerland
NASDAQ
AEON Biopharma, Inc.
California
ANIP
ANI Pharmaceuticals Inc
ANI Pharmaceuticals, Inc.
Minnesota
NASDAQ
ASLN
ASLAN Pharmaceuticals Ltd
Aslan Pharmaceuticals Ltd.
Singapore
NASDAQ
AVEO
AVEO Pharmaceuticals Inc
AVEO Pharmaceuticals, Inc.
Massachusetts
NASDAQ
ABCL
AbCellera Biologics Inc
British Columbia, Canada
NASDAQ
ABT
Abbott Laboratories
Abbott Laboratories engages in the discovery, development, manufacture, and sale of a broad and diversified line of health care products.
Illinois
NYSE
ABBV
Abbvie Inc
AbbVie, Inc.
Illinois
NYSE
ABEO
Abeona Therapeutics Inc
Abeona Therapeutics, Inc.
New York
NASDAQ
ABP
Abpro Corp
Massachusetts
ACAD
Acadia Pharmaceuticals Inc
ACADIA Pharmaceuticals, Inc.
California
NASDAQ
ACST
Acasti Pharma Inc
Acasti Pharma, Inc.
Quebec, Canada
NASDAQ
ACCP
Accelerated Pharma, Inc.
Illinois
NASDAQ
ACRX
Acelrx Pharmaceuticals Inc
AcelRx Pharmaceuticals, Inc.
California
NASDAQ
ACER
Acer Therapeutics Inc
Acer Therapeutics, Inc.
Massachusetts
NASDAQ
AKAOQ
Achaogen, Inc.
Achaogen, Inc.
California
NASDAQ
ACHN
Achillion Pharmaceuticals Inc
We are a clinical-stage biopharmaceutical company focused on advancing our oral small molecule complement system inhibitors into late-stage development and commercialization. Each of the product candidates in our portfolio was discovered in our laboratories and is wholly owned by us. We are focusing our product development activities on complement-mediated diseases where there are no approved therapies or where significant unmet medical need persists despite existing therapies.
Connecticut
NASDAQ